These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4008923)

  • 41. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
    White J; Haskins KM; Marrack P; Kappler J
    J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Production of monoclonal antibodies against human cytomegalovirus].
    Mazeron MC; Berbar T; Guillemin MC; Colimon R; Roseto A; Perol Y
    C R Seances Acad Sci III; 1983; 297(6):305-8. PubMed ID: 6318932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Making monoclonal antibodies.
    Asai DJ; Wilder JK
    Methods Cell Biol; 1993; 37():57-74. PubMed ID: 8255250
    [No Abstract]   [Full Text] [Related]  

  • 44. Production of monoclonal antibodies to a tumor--associated antigen by spontaneous cell fusion.
    Subbiah K; Ananthanarayanan M
    Indian J Cancer; 2000 Mar; 37(1):15-22. PubMed ID: 11261231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production and growth of hybridomas secreting monoclonal antibodies to human thyroid stimulating hormone.
    Denyer MD; Hubbard R; Marks V
    Dev Biol Stand; 1985; 60():493-501. PubMed ID: 4043540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production methods for generating human monoclonal antibodies.
    Glassy MC
    Hum Antibodies Hybridomas; 1993 Oct; 4(4):154-65. PubMed ID: 8257769
    [No Abstract]   [Full Text] [Related]  

  • 47. Behavioral, clinical, and physiologic analysis of mice used for ascites monoclonal antibody production.
    Peterson NC
    Comp Med; 2000 Oct; 50(5):516-26. PubMed ID: 11099135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Membrane-based cell culture systems--an alternative to in vivo production of monoclonal antibodies.
    Nagel A; Koch S; Valley U; Emmrich F; Marx U
    Dev Biol Stand; 1999; 101():57-64. PubMed ID: 10566776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection, purification, and utilization of murine monoclonal IgM antibodies.
    Walker ID
    Methods Mol Biol; 1995; 45():183-8. PubMed ID: 7550681
    [No Abstract]   [Full Text] [Related]  

  • 51. Production and potential use of monoclonal antibodies against polio viruses.
    Osterhaus AD; van Wezel AL; van Steenis G; Hazendonk AG; Drost G
    Dev Biol Stand; 1981; 50():221-8. PubMed ID: 6281107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hollow fibre bioreactors: an alternative to murine ascites for small scale (<1 gram) monoclonal antibody production.
    Lipman NS; Jackson LR
    Res Immunol; 1998; 149(6):571-6. PubMed ID: 9835420
    [No Abstract]   [Full Text] [Related]  

  • 53. Membrane-based cell culture technologies: a scientifically and economically satisfactory alternative to malignant ascites production for monoclonal antibodies.
    Marx U
    Res Immunol; 1998; 149(6):557-9. PubMed ID: 9835418
    [No Abstract]   [Full Text] [Related]  

  • 54. In vivo and in vitro production of monoclonal antibodies: current possibilities and future perspectives. Introduction.
    de Geus B; Hendriksen CF
    Res Immunol; 1998; 149(6):533-4. PubMed ID: 9835413
    [No Abstract]   [Full Text] [Related]  

  • 55. Production of human monoclonal antibody in mouse ascites.
    Truitt KE; Larrick JW; Raubitschek AA; Buck DW; Jacobson SW
    Hybridoma; 1984; 3(2):195-9. PubMed ID: 6480025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monoclonal antibody production: problems and solutions.
    Falkenberg FW
    Res Immunol; 1998; 149(6):542-7. PubMed ID: 9835415
    [No Abstract]   [Full Text] [Related]  

  • 57. Considerations for in vitro monoclonal antibody production.
    Peterson NC
    Res Immunol; 1998; 149(6):553-7. PubMed ID: 9835417
    [No Abstract]   [Full Text] [Related]  

  • 58. Development of monoclonal antibodies reactive with the product of the neu oncogene.
    Drebin JA; Link VC; Stern DF; Weinberg RA; Greene MI
    Symp Fundam Cancer Res; 1986; 38():277-89. PubMed ID: 3749645
    [No Abstract]   [Full Text] [Related]  

  • 59. [The possibility of using outbred mice for the production of monoclonal antibodies].
    Novikov VV; Trofimova MN; Dubinkin IV; Komarova OB; Biriukova LZ
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jul; (7):81-4. PubMed ID: 2816186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cell fusion technics and medical application].
    Kikutani H; Kishimoto T
    Nihon Rinsho; 1982; 40(8):1831-5. PubMed ID: 7143751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.